Gunnar Magnus Modee Persson
Chairman at INITIATOR PHARMA A/S
Net worth: 86 786 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Henrik Kristian Moltke | M | 66 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 8 years |
| Garry Neil | M | 70 | 4 years | |
| Peter Buhl Jensen | M | 69 |
Medical Prognosis Institute, Inc.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 16 years |
| Anki Forsberg | F | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 25 years |
| Magnus Nilsson | M | 68 | 9 years | |
| Christopher Sullivan | M | 40 | 6 years | |
| Gunilla Anders Ekström | M | 66 |
Karolinska Institutet
| 2 years |
| Göran Forsberg | M | 61 | 10 years | |
| Sven Arne Andréasson | M | 72 | 8 years | |
| Carani Sanjeevi | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Karolinska Institutet
| 28 years |
| Claus Elsborg Olesen | M | 50 | 8 years | |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| 4 years |
| Ulf Simonsen | M | 61 | 8 years | |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Peter Holm | M | 50 | 8 years | |
| Flavia Borellini | M | 65 | 4 years | |
| Dino Miano | M | - | - | |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| Annette Colin Lövgren | F | 59 | 3 years | |
| Anders Martin-Löf | M | 53 | 6 years | |
| June Almenoff | M | 67 | 3 years | |
| Steen Meier Knudsen | M | 63 |
Medical Prognosis Institute, Inc.
| - |
| Theresa Tse | F | 32 | 7 years | |
| Christine Lind | F | 50 | 4 years | |
| Hans Schambye | M | 59 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | 13 years |
| Peter Sackey | M | 53 |
Karolinska Institutet
| 4 years |
| Mikael Søndergaard Thomsen | M | 56 | 8 years | |
| Damian Marron | M | 62 | 3 years | |
| Daniel Joseph Calvo | M | - |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Gilla Kaplan | M | 76 | 4 years | |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| 4 years |
| Björn Ingemar Odlander | M | 66 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 28 years |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Mitchell Chan | M | 43 | 3 years | |
| Alex Valcu | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 20 years |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Hans Andreasson | M | 69 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Johan Rutger Christenson | M | 65 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
Karolinska Institutet
| 38 years |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 14 years |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 30 years |
| Johan Edvard Lundin | M | 60 |
Karolinska Institutet
| 12 years |
| Ivan Kamensky | M | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Erik Wiberg | M | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | 10 years |
| Lars Thorsson | M | 63 | 9 years | |
| Magnus Jaderberg | M | - |
Karolinska Institutet
| - |
| Scott Boyer | M | 62 |
Karolinska Institutet
| - |
| Tord Stefan Erik Arver | M | 72 |
Karolinska Institutet
| - |
| Lars Olson | M | - |
Karolinska Institutet
| - |
| David Sharp | M | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | 11 years |
| Maria Hjortsmark | F | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | 12 years |
| Gerrit J. C. van den Dool | M | 70 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Jan Matthew Balmanno Carlstedt-Duke | M | 71 |
Karolinska Institutet
| - |
| Håkan Elmqvist | M | - |
Karolinska Institutet
| - |
| Carl Goldfischer | M | 65 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | 24 years |
| Bernd Seizinger | M | 67 |
Karolinska Institutet
| - |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Bo-Ragnar Tolf | M | 74 |
Karolinska Institutet
| - |
| Madeleine Olsson-Eriksson | M | 79 |
Karolinska Institutet
| - |
| Stig Gösta Ollmar | M | 78 |
Karolinska Institutet
| 27 years |
| Søren Lemonius | M | 59 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Sven-Erik Dahlén | M | - |
Karolinska Institutet
| - |
| Bo Angelin | M | 73 |
Karolinska Institutet
| - |
| Josef M. Miller | M | - |
Karolinska Institutet
| - |
| Klas Gosta Wiman | M | - |
Karolinska Institutet
| - |
| Björn Allan Beermann | M | 83 |
Karolinska Institutet
| - |
| Erik Johan Frostegård | M | 65 |
Karolinska Institutet
| - |
| Mona Ståhle | M | - |
Karolinska Institutet
| - |
| Ulf de Faire | M | - |
Karolinska Institutet
| - |
| Graham Lappin | M | - |
Karolinska Institutet
| - |
| Helén Tuvesson | M | 62 | 4 years | |
| Eva Andersson-Dubin | M | - |
Karolinska Institutet
| - |
| Pär Nordlund | M | 66 |
Karolinska Institutet
| 19 years |
| Håkan Mellstedt | M | 82 |
Karolinska Institutet
| 25 years |
| Lars Ährlund-Richter | M | 72 |
Karolinska Institutet
| - |
| Nanna Liebach Lüneborg | M | 49 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Dorrit T. Andersen | F | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| David Rikard Martinsson Holmdahl | M | 71 |
Karolinska Institutet
| 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Simon Pedder | M | 63 | 2 years | |
| Uli Alf Hacksell | M | 74 | 5 years | |
| Sijme Zeilemaker | M | 37 | 4 years | |
| Blake Paterson | M | 67 | 4 years | |
| Frank Knudsen | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| James Harrell | M | 54 | 4 years | |
| Robert C. Moscato | M | 48 | 1 years | |
| James Cullem | M | 56 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 4 years |
| Thoas Michael Fioretos | M | 66 | 14 years | |
| Carlos de Sousa | M | 66 | 3 years | |
| Joseph Miller | M | 50 | 4 years | |
| Isaac Blech | M | 73 | 8 years | |
| Steven Boyd | M | 43 | 5 years | |
| Federica O’Brien | F | 66 | 2 years | |
| Jim van Heusden | M | 53 | 2 years | |
| Michael Cola | M | 64 | 2 years | |
| Sol Barer | M | 76 | 1 years | |
| Michael Oredsson | M | 64 | 3 years | |
| Eugene Bauer | M | 81 | 2 years | |
| Frank Torti | M | 45 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 66 | 66.00% |
| United States | 21 | 21.00% |
| Denmark | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gunnar Magnus Modee Persson
- Personal Network
